PI3K/Akt路径:黄素治疗效果的一个目标
Mahdieh Aliyari1, Sahar Ghoflchi1, Seyed Isaac Hashemy1
1Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of diabetes and metabolic disorders
|January 23, 2025
概括
黄中的一种化合物库尔库,通过影响酸3-激酶 (PI3K) /蛋白激酶B (Akt) 途径,显示出治疗疾病的潜力. 这一途径对细胞存活和新陈代谢至关重要,黄素对其调节可能会带来治疗效益.
科学领域:
- 药理学和分子生物学
- 细胞信号传输 细胞信号传输
- 自然产品研究自然产品研究
背景情况:
- 从黄中提取的黄素表现出多种不同的药理特性.
- 氨基酸3-激酶 (PI3K) /蛋白激酶B (Akt) 信号通路调节了关键的细胞功能,如生长,生存,新陈代谢和亡.
- PI3K/Akt路径的调节失调与各种疾病有关.
研究的目的:
- 审查黄素对PI3K/Akt信号通路的影响.
- 探索黄素在慢性疾病中的治疗潜力,包括心血管疾病,2型糖尿病,肥胖,非酒精性脂肪肝疾病,脏疾病和神经退行性疾病.
主要方法:
- 使用PubMed,谷歌学者和Scopus进行了系统的文献搜索.
- 标题/摘要中的关键词包括"酸3-激酶"",蛋白激酶B"和"黄素".
- 在全文中搜索了与特定疾病相关的其他关键词.
主要成果:
- 黄素对多种健康状况具有潜在的益处.
- 研究表明,黄素可以帮助调节血糖,减少炎症,并保护心脏,脏和大脑.
结论:
- 黄素的保护作用部分通过调节PI3K-Akt生存途径来调节.
- 这种调节可以改善代谢障碍和氧化应激.
- 了解黄素对PI3K/Akt路径的影响,可以为各种疾病提供新的治疗策略.
关键词:
长 (Curcuma longa) 是一种长.库尔库明是一种黄素.脏疾病 脏疾病代谢性疾病是一种代谢性疾病.神经退行性疾病是一种神经退行性疾病.氏酸3-酶酶是一种酸.蛋白质激酶B的蛋白质激酶B.更多相关视频
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K


